Ambu A/S (OTCMKTS:AMBBY – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.10 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a return on equity of 4.11% and a net margin of 4.30%.
Ambu A/S Price Performance
Ambu A/S stock remained flat at $19.01 during mid-day trading on Thursday. The firm has a market capitalization of $4.47 billion and a P/E ratio of 158.38. Ambu A/S has a 12-month low of $13.02 and a 12-month high of $22.65. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.49 and a quick ratio of 1.47. The stock’s 50 day moving average is $15.81 and its 200-day moving average is $18.09.
Ambu A/S Dividend Announcement
The company also recently disclosed a dividend, which was paid on Monday, December 23rd. Shareholders of record on Friday, December 6th were given a $0.0557 dividend. The ex-dividend date was Friday, December 6th. Ambu A/S’s payout ratio is 25.00%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Articles
- Five stocks we like better than Ambu A/S
- Retail Stocks Investing, Explained
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- Stock Market Upgrades: What Are They?
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
- The Risks of Owning Bonds
- Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
